Skip to content

Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan

The Clinical Study of the Microbial Colonization of Chronic Keratinized Hand Eczema and the Change of Microbial Colonization After External Using of Halometasone Triclosan Cream

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03246776
Acronym
MCCK
Enrollment
80
Registered
2017-08-11
Start date
2017-08-20
Completion date
2017-12-08
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hand Eczema

Brief summary

The clinical study of the microbial colonization of chronic keratinized hand eczema and the change of microbial colonization after external using of Halometasone Triclosan Cream

Detailed description

The clinical study of the microbial colonization of chronic keratinized hand eczema and the change of microbial colonization after external using of Halometasone Triclosan Cream

Interventions

DRUGHalometasone Triclosan

Halometasone Triclosan . The study product will be applied topically twice a day (morning and evening) for 14 days of treatment

Sponsors

Beijing Friendship Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

open label

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Chronic Keratinized hand eczema for at least 3 months * The affected area is greater than 30% * Overall assessment of the severity of the disease(IGA)≥3 OR HEES≥13 * No obvious incentive .Who have read the instructions of the subject, agreed to and signed written informed consent, and have been able to provide a personal medical history.

Exclusion criteria

* Pregnancy, breast feeding * Severe liver and kidney disease, blood system disease, autoimmune disease, chronic severe infection, diabetes, mental illness, drug use, alcohol abuse, etc * Malignant neoplasms or other serious maladies that may affect the correct assessment of efficacy * Topical corticosteroid was suspended for less than 2 weeks;The system used corticosteroids and other immunosuppressive agents (thunder vine and other drugs) which were suspended for less than four weeks * Eczema of the facial and skin creases * Atopic dermatitis, contact dermatitis, blister hand eczema, contact urticaria, discoid eczema * participated in other clinical trials within 3 months. * Known sensitivity to Halometasone Triclosan * failure to follow the prescribed medication or the incomplete record of the test process which will affect the curative effect judgment * Other reasons why researchers think they should not be included

Design outcomes

Primary

MeasureTime frameDescription
Response to Hand eczema severity2 weeksHEES(hand eczema extent score)

Secondary

MeasureTime frameDescription
Response to treatment/Hand eczema severity2 weeksPhotographic evaluation
Investigator reported improvement2 weeksIGA(investigator's global assessment)
Response to Quality of Lifeweek 0 and 2questionnaire :DLQI(dermatology life quality index)
Patient Reported Improvementup to 2 weeksVAS(Visual Analog Score for pruritus)
Response to Microbial Colonization rates2 weeksStaphylococcus aureus colonization rates

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026